Literature DB >> 12019125

TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.

J Kamile Rasheed1, Gregory J Anderson, Anne Marie Queenan, James W Biddle, Antonio Oliver, George A Jacoby, Karen Bush, Fred C Tenover.   

Abstract

TEM-71, a novel extended-spectrum beta-lactamase from a Klebsiella pneumoniae clinical isolate, had an isoelectric point of 6.0 and a substrate profile showing preferential hydrolysis of cefotaxime over ceftazidime. It differed from TEM-1 by two substitutions, Gly238Ser and Glu240Lys, and was under the control of the strong P4 promoter.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12019125      PMCID： PMC127224          DOI： 10.1128/AAC.46.6.2000-2003.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.

Authors:  M Yuan; L M Hall; P H Savelkoul; C M Vandenbroucke-Grauls; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

2.  Updated sequence information and proposed nomenclature for bla(TEM) genes and their promoters.

Authors:  V Leflon-Guibout; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 3.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.

Authors:  V Leflon-Guibout; V Speldooren; B Heym; M Nicolas-Chanoine
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Updated sequence information for TEM beta-lactamase genes.

Authors:  S Goussard; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

6.  Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 7.  Methodology for the study of beta-lactamases.

Authors:  K Bush; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

8.  Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime.

Authors:  Annie Wong-Beringer; Janet Hindler; Michael Loeloff; Anne Marie Queenan; Nancy Lee; David A Pegues; John P Quinn; Karen Bush
Journal:  Clin Infect Dis       Date:  2001-12-04       Impact factor: 9.079

9.  Two improved promoter sequences for the beta-lactamase expression arising from a single base-pair substitution.

Authors:  S T Chen; R C Clowes
Journal:  Nucleic Acids Res       Date:  1984-04-11       Impact factor: 16.971

10.  SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.

Authors:  L Gutmann; B Ferré; F W Goldstein; N Rizk; E Pinto-Schuster; J F Acar; E Collatz
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191
View more
  6 in total

1.  New TEM-derived extended-spectrum beta-lactamase and its genomic context in plasmids from Salmonella enterica serovar derby isolates from Uruguay.

Authors:  Rafael Vignoli; Nicolas F Cordeiro; Virginia García; María Inés Mota; Laura Betancor; Pablo Power; José A Chabalgoity; Felipe Schelotto; Gabriel Gutkind; Juan A Ayala
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.

Authors:  George A Jacoby; Kelley E Walsh; Victoria J Walker
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.

Authors:  Pierre-Yves De Wals; Nicolas Doucet; Joelle N Pelletier
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

4.  Occurrence of CTX-M Producing Escherichia coli in Soils, Cattle, and Farm Environment in France (Burgundy Region).

Authors:  Alain Hartmann; Aude Locatelli; Lucie Amoureux; Géraldine Depret; Claudy Jolivet; Eric Gueneau; Catherine Neuwirth
Journal:  Front Microbiol       Date:  2012-03-09       Impact factor: 5.640

5.  The impact of production of extended-spectrum β-lactamases on the 28-day mortality rate of patients with Proteus mirabilis bacteremia in Korea.

Authors:  Jin Young Ahn; Hea Won Ann; Yongduk Jeon; Mi Young Ahn; Dong Hyun Oh; Yong Chan Kim; Eun Jin Kim; Je Eun Song; In Young Jung; Moo Hyun Kim; Wooyoung Jeong; Nam Su Ku; Su Jin Jeong; Jun Yong Choi; Dongeun Yong; Young Goo Song; June Myung Kim
Journal:  BMC Infect Dis       Date:  2017-05-03       Impact factor: 3.090

6.  Escherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan.

Authors:  Yutaka Shiraki; Naohiro Shibata; Yohei Doi; Yoshichika Arakawa
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.